3Alderson P,Green S,Higgins J.Cochrane Reviewers’Handbook 4.2.3[Updated November 2004][M/OL].The Cochrane collaboration,[2011-10-18].www.stirrhs.ca/files/handbook.pdf.
4Grander D.How does interferon-alpha exert its antitumour activity inmultiple myeloma?[J].Acta Oncol,2000,39(7):801-805.
5Xu D,Erickson S,Szeps M,et al.Interferon alpha down-regulatestelomerase reverse transcriptase and telomerase activity in hum anmalignant and nonmalignant hematopoietic cells[J].Blood,2000,96(13):4313-4318.
6Chiron D,Pellat-Deceunynck C,Amiot M,et al.TLR3 ligandinduces NF-{kappa}B activation and various fates of multiplemyeloma cells depending on IFN-{alpha}production[J].J Immunol,2009,182(7):4471-4478.
7Ahre A,Bj rkholm M,Mellstedt H,et al.Human leukocyteinterferon and intermittent high-dose melphalan-prednisoneadministration in the treatment of multiple myeloma:a randomizedclinical trial from the Myeloma Group of Central Sweden[J].Cancertreat Rep,1984,68(11):1331-1338.
